Literature DB >> 3013216

Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents.

A N Orekhov, V V Tertov, S A Kudryashov, Kh A Khashimov, V N Smirnov.   

Abstract

Smooth muscle cells isolated from atherosclerotic lesions of human aorta retain in primary culture their intrinsic in vivo characteristics: namely, enhanced proliferative activity and high lipid levels. We have tested the effect of different compounds on [3H]thymidine uptake and on the levels of phospholipids, triglycerides, cholesterol, and cholesteryl esters in cultured aortic cells. Effects, such as the inhibition of cellular proliferation and/or lowering of the intracellular lipid levels which would be regarded as antiatherosclerotic if exerted in vivo, were observed in vitro by the following compounds: dibutyryl cyclic AMP, cholera toxin, forskolin, methylisobutylxanthine, stable prostacyclin analogues, prostaglandins E2 and D2, verapamil, reserpine, alpha-tocopherol, butylated hydroxytoluene, lipostabil, and high density lipoproteins. In this paper, we discuss the possibility of using a primary culture of smooth muscle cells from an atherosclerotic human aorta for testing drugs for possible antiatherosclerotic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013216     DOI: 10.1016/0021-9150(86)90002-x

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

Review 1.  New insights into atherosclerotic plaque rupture.

Authors:  D M Braganza; M R Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

2.  Effect of trifluoperazine on certain arterial wall lipid-metabolizing enzymes inducing atherosclerosis in rhesus monkeys.

Authors:  A Mohindroo; P Ahluwalia
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

3.  Use of human atherosclerotic cells for optimization of antiatherosclerotic therapy.

Authors:  A N Orekhov
Journal:  Agents Actions       Date:  1991-01

4.  Proliferative and synthetic activity of cells from reoccluded distal anastomosis and pharmacological therapy of this postoperative complication.

Authors:  N M Orekhova
Journal:  Agents Actions       Date:  1991-01

5.  Influence of no-donor (SIN-1) on functions of inflammatory cells.

Authors:  A Dembińska-Kieć; A Zmuda; J Marcinkiewicz; H Sinzinger; R J Gryglewski
Journal:  Agents Actions       Date:  1991-01

Review 6.  The interaction of prostaglandin E1 with serum lipoproteins. Possible role in cholesterol homeostasis.

Authors:  L D Bergelson
Journal:  Lipids       Date:  1990-12       Impact factor: 1.880

7.  Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene.

Authors:  J L Parkes; R R Cardell; F C Hubbard; D Hubbard; A Meltzer; A Penn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

8.  Lipid biosynthesis in cultured arterial smooth muscle cells is related to their phenotype.

Authors:  E Dusserre; M C Bourdillon; M Ciavatti; C Covacho; S Renaud
Journal:  Lipids       Date:  1993-07       Impact factor: 1.880

9.  Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.

Authors:  A N Orekhov; E M Pivovarova; I A Sobenin; V V Yakushkin; V V Tertov
Journal:  Drugs       Date:  1992       Impact factor: 9.546

10.  Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells.

Authors:  Takayuki Fujino; Koh-ichi Yuhki; Takehiro Yamada; Akiyoshi Hara; Osamu Takahata; Yuji Okada; Chun-Yang Xiao; Hong Ma; Hideji Karibe; Yasunori Iwashima; Jun Fukuzawa; Naoyuki Hasebe; Kenjiro Kikuchi; Shuh Narumiya; Fumitaka Ushikubi
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.